Researchers believe they have developed a test to identify people who have dormant cancer cells and a drug regimen to kill ...

Now, the Chicago pharma has done just that by striking a deal with a slate of generics manufacturers that waylays the entry ...

AbbVie doesn’t expect generic Rinvoq products to be launched in the United States before April 2037, per an MSN report.

The news that the brand is protected from generics for more than a decade "gives AbbVie a kind of tremendous runway," to sell ...

Rapamycin is an immune suppressant often used in organ transplant patients, but it has also been shown to extend life in animals, including flies and mice.

The biopharmaceutical company doesn’t expect U.S. generic entry for the drug before 2037 now that it has settled litigation.

Generic drugs account for more than 90 percent of prescriptions filled in the United States. Recent studies have found concering variability in quality and safety America’s generic drug supply, most ...

While 2025 began on a positive note for the pharmaceutical industry, things have taken a sharp turn amid escalating fears of a global trade war. While Trump had initially exempted pharmaceuticals from ...

Biocon CEO Siddharth Mittal reveals plans to launch generic versions of diabetes drug Ozempic in key markets by the end of ...

Generic drugmakers continue to face mounting pressure not only from pricing competition but also from Trump’s push for pharmaceutical import tariffs and the proposed “most-favored-nation” pricing ...

Boryung Co., Ltd. (CEO Kim Jeong-gyun) is focusing on stably producing and supplying essential medicines necessary for public ...